noted within the normally anechoic lumen. Further evaluation demonstrated a solid, nonmobile, noncompressible, intraluminal abnormality located inferior to the left renal vein and superior to the venous confluence, which is highly suggestive of inferior vena cava thrombosis or possible neoplasm. In an effort to determine a source of origin, lower extremity veins were examined using a combination of gray-scale, color Doppler, and compression techniques with a 5-MHz linear transducer to assess for deep vein thrombosis (DVT) with possible propagation into the IVC. Renal veins were assessed for patency and possible tumor invasion. The kidneys were also assessed for possible neoplasm. All were determined to be within normal limits. The student was directed to the emergency room under the suspicion of inferior vena cava thrombosis (IVCT) versus neoplasm.
An IVC sonogram, in conjunction with a computed tomography angiogram (CTA) of the abdomen and pelvis, which was ordered through the emergency department, confirmed the initial suspicion of IVCT. High-resolution real-time gray-scale imaging with compression technique and color Doppler evaluation was performed along the length of the IVC in transverse and longitudinal planes (Figures 1-3) . A Philips ATL iU22 (Bothell, WA) with a C5 curved linear array transducer was used to demonstrate a 0.9-cm transverse × 4.2-cm-long filling defect superior to the venous confluence and inferior to the renal veins. There appeared to be spontaneous blood flow around but not within the abnormality (Figures 4 and 5 ). The lack of internal perfusion combined with the computed tomography examination findings suggested a diagnosis of thrombosis, or clot formation, over neoplasm. The sonogram also demonstrated "flailing" edges of the thrombus in real time. Helical imaging of the abdomen and pelvis using intravenous (IV) contrast and CTA protocol demonstrated findings consistent with the sonographic data ( Figure 6 ). The lesion did not appear to cause occlusion of the IVC, nor did the vessel appear dilated. The patient was administered IV heparin drip anticoagulation therapy and admitted to the hospital for further workup, which included bilateral lower extremity venous Doppler studies and extensive lab work, all of which were considered within normal limits.
The patient was instructed to discontinue current oral contraceptives, and after consultation between the primary physician and interventional radiologist, a treatment plan of anticoagulation therapy as well as insertion of a vena cava filter as a prophylaxis measure was implemented. Therefore, an OptEase vena cava filter was placed under fluoroscopic guidance via jugular vein catheter insertion with inferior vena cavography and deployed A 24-hour postinsertion supine radiograph of the abdomen demonstrated adequate filter expansion with no evidence of migration ( Figure 9 ). The patient was monitored until proper anticoagulation levels were reached and then released from the hospital with instructions regarding monitoring her blood-clotting factors through lab work and for a three-month follow-up sonogram to evaluate the thrombus.
According to the student, the three-month followup IVC sonogram demonstrated no evidence of residual thrombus. Anticoagulation therapy was discontinued, and she was released from her physician. The vena cava filter will remain in place. No follow-up images were obtainable at the time of journal submission.
Discussion
The inferior vena cava originates at the junction of the two common iliac veins anterior to the body of the fifth lumbar vertebra. It ascends vertically through the retroperitoneal space on the right side of the aorta posterior to the liver, where it passes through the diaphragm to enter the right atrium of the heart. 1, 2 Tributaries to the IVC include the hepatic veins, renal veins, common iliac veins, right adrenal vein, right ovarian vein or testicular vein, inferior phrenic vein, four lumbar veins, and a medial sacral vein. 2 The primary function of the IVC is venous return of deoxygenated blood from all organs and structures from the upper and lower abdomen and lower extremities to the heart for oxygenation and recirculation. The sonographic appearance of the normal IVC includes echogenic, muscular walls and an anechoic, echo-free lumen. 2 The vessel should demonstrate compressibility and also spontaneous, phasic changes in vessel diameter associated with patient respirations. Thrombosis, or clot formation, within the inferior vena cava appears as a homogeneous echo mass. 2 There is also a lack of or reduction in compressibility and spontaneous, phasic flow.
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3 describes IVCT as a subset of DVT. Clinical variability in presentation of symptoms makes it difficult to determine the exact number of patients with IVCT or DVT. It is estimated that DVT affects more than 500,000 individuals annually in the United States, and incidence rates are estimated to be 70 to 113 cases per 100,000 population annually. 4 Risk factors and stimuli contributing to thrombus or blood clot formation are characteristic throughout the entire venous system. In 1856, Rudolph Virchow classified these into three general classification areas of (1) hypercoagulable state, or an increased tendency for blood to clot; (2) venous stasis (blood slows or pools in the veins); and (3) vein wall injury. [3] [4] [5] [6] Risk factors include "age (greater than 40 years old), malignancy, previous DVT or pulmonary emboli (PE), immobilization, fracture of the pelvis, hips or long bones, myocardial infarction, stroke, congestive heart or respiratory failure, pregnancy and postpartum, oral contraceptives and hormone replacement therapy, surgery, trauma, hereditary factors, obesity, central venous lines, intravenous drug use, etc." 2 In this particular case, the patient's oral contraceptive use possibly rendered a hypercoagulable state, 7 and the extended driving times could have contributed to venous stasis, 7 constituting two of three of Virchow's risk classifications.
A potentially lethal complication of DVT is pulmonary embolism. 4 A blood clot that breaks loose from a deep vein is termed an embolus. An embolus can travel through the bloodstream through the heart and into a vessel in the lung, blocking blood flow. It has been shown that the majority of life-threatening pulmonary emboli originate in the proximal deep veins of the leg. 8 Signs and symptoms associated with pulmonary embolus include dyspnea (shortness of breath), chest pain, hemoptysis, sweats, and cough. 4, 6, 7 Signs and symptoms relating to inferior vena cava thrombus vary depending on the extent and involvement of the clot. About half of the people with DVT have no symptoms. 6, 7 Isolated thrombus with unobstructed flow and without involvement of other vessels may present as asymptomatic (no signs or symptoms), as in this case study. Findings associated with other conditions such as unilateral or bilateral DVT may present as unilateral or bilateral leg edema and/or pain. IVCT with pulmonary embolism may present with shortness of breath, dyspnea, or even cardiac arrest. The extreme variance in the degree of symptoms contributes greatly to the degree of difficulty in accurately diagnosing IVCT, and many times it becomes an incidental finding.
Diagnostic tools for evaluation may vary with symptoms. For lower extremity DVT, contrast venography remains the gold standard. However, high-resolution, real-time lower extremity venous Doppler sonograms using 5-to 7-MHz linear transducers with compression evaluation are becoming the examination of choice given the noninvasive, portable nature of the study. Computed tomography and magnetic resonance imaging often serve as diagnostic tools for evaluating the IVC and may be used in conjunction with sonography. Nuclear medicine ventilation and perfusion scans or CTA are most often used to evaluate for pulmonary embolism. More often than not, it is a combination of imaging modalities that is used for diagnosis.
A more controversial indicator used in diagnosing IVCT/DVT is the D-dimer blood test. 5 ,7 D-dimer is a clot-dissolving substance in the blood that "reflects intravascular fibrin turnover and intravascular thrombogenesis." 5 The level of D-dimer is always elevated in patients with severe DVT; however, it becomes elevated in other conditions as well, rendering the results inconclusive. It has usefulness in ruling out DVT. 7 Treatment for IVCT/DVT is predominantly focused on preventing pulmonary emboli, reducing thrombus, and preventing future thrombus formation. Treatment types include anticoagulation therapy, thrombolytic agents, and/or filters. 7 Anticoagulants, also known as blood thinners, are drugs that inhibit the blood's ability to clot. The two most common drugs are heparin and warfarin (Coumadin). Heparin has a shorter response time for thinning the blood and is usually given once diagnosis of clot formation is suspected or confirmed. Warfarin takes longer to reach effective blood levels, increases the risk of bleeding, and must be monitored by blood test to maintain appropriate levels.
Thrombolytic agents, or clot busters, are more aggressive drugs given intravenously to break up clots. A more common type is called tissue plasminogen activator (tPA). These drugs are most often used as a last resort when other medications fail; they carry a very serious risk of bleeding and are, therefore, reserved for use in more lifethreatening situations. 7 An IVC filter, more commonly known as a "Greenfield" or "umbrella" filter, may be placed in the IVC between the clot and the heart to trap emboli. There is much debate about the accepted clinical indications for filter placement. Historically, absolute clinical indications for insertion of an IVC filter included a patient history of pulmonary emboli and/or contraindications for anticoagulation therapy. However, the literature demonstrates a shift toward placement as a prophylaxis even in patients with no contraindications to blood thinners. 9, 10 These filters vary in material, size, deployment, and permanency. Most are made of a tubular wire or synthetic mesh and can be deployed via an internal jugular vein or femoral vein catheterization. Once deployed, anchoring barbs help prevent the filter from migrating. Most filters are permanent, but some more recent types, such as the Optease used in this case, possess unidirectional barbs that allow for future retrieval. As in any procedure, complications can arise from insertion and/or removal of an IVC filter; the physician must take care in weighing the risks versus the possible benefits in each case.
Prognosis of inferior vena cava thrombosis varies from excellent to poor, depending on the location, extent, and nature of the clot itself; preexisting or underlying medical conditions; degree of involvement or propagation to and from other organs; and at what stage the diagnosis is made and when treatment is begun. In this particular case, the IVCT was focal and isolated without pulmonary embolism or DVT. Her prognosis was excellent, and at the time of journal submission, 11 months after diagnosis, the patient remains clot free.
Conclusion
Detection of primary inferior vena cava thrombosis in an asymptomatic patient is a rare occurrence. The student would have no reason to seek treatment until the process was more extensive, such as complete inferior vena cava occlusion, deep vein thrombosis, or pulmonary embolism. Because patients do not normally present until there is further complication, it is difficult to classify the actual number of cases of primary inferior vena cava thrombosis. Where clinically indicated, real-time sonography is a noninvasive, accurate, and efficient method for diagnosing and further characterizing inferior vena cava thrombus.
